Rheumatoid arthritis (RA) can be a challenging and painful condition to manage. Biologics are one type of disease-modifying antirheumatic drugs (DMARDs) your doctor might prescribe to treat RA.

Biologic disease-modifying antirheumatic drugs (DMARDs) such as adalimumab, etanercept and infliximab are effective at reducing symptoms and slowing progression of rheumatoid arthritis (RA).

A study found patients treated with interleukin inhibitors did not experience a difference in the rates of major adverse ...

Although sustained remission free of disease-modifying antirheumatic drugs “does not seem attainable” for patients with ...

Further research is needed to determine the risks and benefits of particular sequences of biologic therapies in patients with rheumatoid arthritis who require treatment change owing to inefficacy ...

No matter a person’s actual age, everyone ages at a different rate. This is chronological age vs. biological age. We all know ...

Below is a review of novel drug and biological products approved by the Food and Drug Administration (FDA) in 2024. The list includes several groundbreaking therapies that are expected to change the ...

Arthritis can affect your fingers causing reduced mobility pain and swelling Read on to check the types of arthritis ...

Adalimumab and secukinumab are the only FDA-approved biologic drugs to treat hidradenitis suppurativa, limiting options for ...

New developments in regenerative medicine are providing alternative solutions that aim to address the underlying issues of ...

Differences in rates of bDMARD treatment initiation among US veterans with RA living in rural vs urban areas cannot be fully explained by location.